Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) have been given an average recommendation of “Buy” by the twelve ratings firms that are presently covering the company, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have covered the stock in the last year is $44.58.
A number of brokerages recently issued reports on PRVA. Canaccord Genuity Group upped their target price on Privia Health Group from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, August 25th. Cowen upped their target price on Privia Health Group from $35.00 to $44.00 and gave the company an “outperform” rating in a research report on Friday, August 12th. Canaccord Genuity Group increased their price objective on Privia Health Group from $45.00 to $50.00 in a research report on Thursday, August 25th. BTIG Research increased their price objective on Privia Health Group to $45.00 in a research report on Monday, August 15th. Finally, Guggenheim increased their price objective on Privia Health Group from $36.00 to $51.00 and gave the stock a “buy” rating in a research report on Friday, August 12th.
Privia Health Group Stock Down 2.2 %
Shares of NASDAQ PRVA opened at $41.27 on Friday. The stock has a market cap of $4.59 billion, a PE ratio of -89.72 and a beta of 1.06. Privia Health Group has a 52-week low of $17.99 and a 52-week high of $44.64. The business has a 50-day moving average price of $36.94 and a 200 day moving average price of $29.34.
Insider Transactions at Privia Health Group
Hedge Funds Weigh In On Privia Health Group
Hedge funds have recently bought and sold shares of the company. Assetmark Inc. increased its stake in Privia Health Group by 119.4% in the 2nd quarter. Assetmark Inc. now owns 893 shares of the company’s stock valued at $26,000 after purchasing an additional 486 shares in the last quarter. Rockefeller Capital Management L.P. purchased a new position in Privia Health Group in the 4th quarter valued at approximately $25,000. First Horizon Advisors Inc. purchased a new position in Privia Health Group in the 4th quarter valued at approximately $26,000. Nisa Investment Advisors LLC purchased a new position in Privia Health Group during the second quarter worth $46,000. Finally, Point72 Hong Kong Ltd purchased a new position in Privia Health Group during the first quarter worth $47,000. 62.81% of the stock is owned by hedge funds and other institutional investors.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
- Get a free copy of the StockNews.com research report on Privia Health Group (PRVA)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.